While this hypothesis has been extrapolated to account for sporadic AD, it is important to note that sporadic AD patients do not have mutations in APP or PS genes, and the molecular basis for the accumulation of neurotoxic forms of Aβ is unknown [96]. This evidence concerns the gene APP and Alzheimer disease.